English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide -- PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer Journal article
Lyu, P., Ge, L., Ma, R., Wei, R., McCrudden, C. M., Chen, T., Shaw, C., Kwok, H. F.. Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide -- PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer[J]. Scientific Reports, 2018, 14502---.
Authors:  Lyu, P.;  Ge, L.;  Ma, R.;  Wei, R.;  McCrudden, C. M.; et al.
Favorite |   IF:3.8/4.3 | Submit date：2022/06/02
Amphibian skin peptide  Pelophylax esculentus  Bowman-Birk-like trypsin inhibitor  Anticancer peptide  Drug discovery  
CD133 in brain tumor: the prognostic significance factor Journal article
Li, B., McCrudden, C. M., Yuen, H. F., Xi, X., Peng, P., Chan, K. W., Zhang, S. D., Kwok, H. F.. CD133 in brain tumor: the prognostic significance factor[J]. Oncotarget, 2016, 11144-11159.
Authors:  Li, B.;  McCrudden, C. M.;  Yuen, H. F.;  Xi, X.;  Peng, P.; et al.
Favorite |   IF:5.168/5.312 | Submit date：2022/06/02
Brain tumor  CD133  HOX  LIM2  Stem cell  Survival  
Prognostic significance of combining VEGFa, FLT1 and KDR mRNA expressions in lung cancer Journal article
Zhang, S. D., McCrudden, C. M., Kwok, H. F.. Prognostic significance of combining VEGFa, FLT1 and KDR mRNA expressions in lung cancer[J]. Oncology Letters, 2015, 1893-1901.
Authors:  Zhang, S. D.;  McCrudden, C. M.;  Kwok, H. F.
Favorite |   IF:2.5/2.4 | Submit date：2022/06/02
VEGFa  FLT1  KDR  prognostic marker  lung cancer cohorts  
The significance of combining VEGFa, FLT1 and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab Journal article
Zhang, S.D., McCrudden, C.M., Meng, C., Lin, Y., Kwok, H. F.. The significance of combining VEGFa, FLT1 and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab[J]. Oncotargets & Therapy, 2015, 835-843.
Authors:  Zhang, S.D.;  McCrudden, C.M.;  Meng, C.;  Lin, Y.;  Kwok, H. F.
Favorite |   IF:2.7/3.1 | Submit date：2022/06/02
Colon cancer  VEGFa  FLT1  KDR  Angiogenesis  Survival  
The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab Journal article
Zhang S.-D., McCrudden C.M., Meng C., Lin Y., Kwok H.F.. The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab[J]. OncoTargets and Therapy, 2015, 8, 835-843.
Authors:  Zhang S.-D.;  McCrudden C.M.;  Meng C.;  Lin Y.;  Kwok H.F.
Favorite | TC[WOS]:28 TC[Scopus]:17 | Submit date：2018/12/19
Angiogenesis  Colon Cancer  Flt1  Kdr  Survival  Vegfa  
The prognostic significance of PD-L1 in bladder cancer Journal article
Huang Y., Zhang S.-D., McCrudden C., Chan K.-W., Lin Y., Kwok H.-F.. The prognostic significance of PD-L1 in bladder cancer[J]. Oncology Reports, 2015, 33(6), 3075.
Authors:  Huang Y.;  Zhang S.-D.;  McCrudden C.;  Chan K.-W.;  Lin Y.; et al.
Favorite | TC[WOS]:89 TC[Scopus]:96 | Submit date：2018/10/30
Bladder Cancer  Patient Survival  Prognostic Marker  Programmed Death Ligand-1  Therapeutic Targets